← All stocks

UNITED THERAPEUTICS Corp

UTHR Scheduled selling only
CIK 0001082554 #683 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$109.93M
$0.00 on a plan · $109.93M straight out of an exercise
Sold at will
$0.00
0 of 242 sales
Net
−$109.93M
$0.00 against sales at will

By person

14 insiders · 242 transactions
122×

Martine Rothblatt holds 122 times base salary in stock. $188.72M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $504.57, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ROTHBLATT MARTINE A
Chairperson & CEO
$101.47M (220) scheduled
−$101.47M
374,024
0.8720%
$188.72M
+6.9%
MAHON PAUL A
EVP & GENERAL COUNSEL
$8.34M (20) scheduled
−$8.34M
45,172
0.1053%
$22.79M
+22.6%
Mesa Nilda
Director
$115.34K (2) scheduled
−$115.34K
5,580
0.0130%
$2.82M
−7.1%
Giltner Richard
Director
21,884
0.0510%
$11.04M
+25.6%
BENKOWITZ MICHAEL
PRESIDENT AND COO
19,046
0.0444%
$9.61M
−83.8%
EDGEMOND JAMES
CFO AND TREASURER
18,876
0.0440%
$9.52M
+331.0%
KURZWEIL RAY
Director
13,320
0.0311%
$6.72M
+10.3%
Thompson Tommy G
Director
8,480
0.0198%
$4.28M
0.0%
Olian Judy D.
Director
5,555
0.0130%
$2.80M
−25.0%
CAUSEY CHRISTOPHER
Director
4,190
0.0098%
$2.11M
+5.8%
SULLIVAN LOUIS W
Director
2,983
0.0070%
$1.51M
−79.8%
PATUSKY CHRISTOPHER
Director
2,140
0.0050%
$1.08M
+137.8%
DWEK RAYMOND
Director
1,750
0.0041%
$883.00K
0.0%
MALCOLM JAN
Director
450
0.0010%
$227.06K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 242
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 216,230
History held since 2 Sep 2016